Free shipping on all orders over $ 500

TAK-632

Cat. No. M2235
TAK-632 Structure
Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
5mg USD 35  USD35 In stock
10mg USD 50  USD50 In stock
25mg USD 86  USD86 In stock
50mg USD 140  USD140 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

TAK-632 is a selective kinase inhibitor targeting pan-RAF inhibition. TAK-632 inhibited phosphorylation of MEK (pMEK) in melanoma A375 cells (BRAFV600E) with an IC50 value of 12 nM. TAK-632 suppresses RAF activity in BRAF wild-type cells with minimal RAF paradoxical activation. TAK-632 induces RAF dimerization but inhibits the kinase activity of the RAF dimer, probably because of its slow dissociation from RAF. TAK-632 demonstrates potent antiproliferative effects both on NRAS-mutated melanoma cells and BRAF-mutated melanoma cells with acquired resistance to BRAF inhibitors through NRAS mutation or BRAF truncation.

Customer Product Validations & Biological Datas
Source Cancer Res (2013). Figure 1. TAK-632
Method Western blot analysis
Cell Lines A431, CsFb, and HeLa cells
Concentrations 0-5000 nmol/L
Incubation Time 2 h
Results MEK and ERK phosphorylation was modestly induced at low TAK-632 concentrations but inhibited at higher concentrations in BRAF wild-type cells
Chemical Information
Molecular Weight 554.52
Formula C27H18F4N4O3S
CAS Number 1228591-30-7
Solubility (25°C) DMSO 90 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Hao Zhang, et al. N-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[ d]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) Analogues as Novel Necroptosis Inhibitors by Targeting Receptor-Interacting Protein Kinase 3 (RIPK3): Synthesis, Structure-Act䲧畸Ỵ畹㧀畷羹皖睑ꏰऒŤऒĀ

[2] Xiaofei Chen, et al. Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3

[3] Xiaokai Li, et al. Design and synthesis of N-(4-aminopyridin-2-yl)amides as B-Raf(V600E) inhibitors

[4] Akito Nakamura, et al. Antitumor activity of the selective pan-RAF inhibitor TAK-632 in BRAF inhibitor-resistant melanoma

[5] Masanori Okaniwa, et al. Discovery of a selective kinase inhibitor (TAK-632) targeting pan-RAF inhibition: design, synthesis, and biological evaluation of C-7-substituted 1,3-benzothiazole derivatives

Related Raf Products
Cyclorasin 9A5

Cyclorasin 9A5 is an 11-residue cell-permeable cyclic peptide that orthosterically inhibits the Ras-Raf protein interaction with an IC50 of 120 nM.

R18

R18 is a peptide antagonists of 14-3-3, with a KD of 70-90 nM.

PROTAC RAF degrader 1

PROTAC RAF degrader 1 is a PROTAC RAF degrader.

B-Raf IN 15

B-Raf IN 15 is a BRAF inhibitor.

Raf inhibitor 3

Raf inhibitor 3 is a Raf inhibitor.

  Catalog
Abmole Inhibitor Catalog




Keywords: TAK-632 supplier, Raf, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.